Yeast cells having reductive TCA pathway from pyruvate to succinate and overexpressing an exogenous NAD(P+) transhydrogenase enzyme
US11821021B2 · kind B2 · utility
0Cited by
15References
15Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jun 15, 2021 |
| Grant date | Nov 21, 2023 |
| Priority date | — |
| Expiry date | Jun 15, 2041 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY02E50/30
- WIPO fieldBiotechnology
- WIPO sectorChemistry
Abstract
Yeast cells having a reductive TCA pathway from pyruvate or phosphoenolpyruvate to succinate, and which include at least one exogenous gene overexpressing an enzyme in that pathway, further contain an exogenous transhydrogenase gene.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.